$3.480
-0.251 (-7.20%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Unicycive Therapeutics Inc (UNCY) Moving Averages Convergence Divergence (MACD) indicator is -0.22, suggesting UNCY is Strong sell.
Unicycive Therapeutics Inc (UNCY) 20-Day simple moving average is 3.72, while Unicycive Therapeutics Inc (UNCY) share price is $—, making it Sell.
Unicycive Therapeutics Inc (UNCY) 60-Day simple moving average is 4.57, while Unicycive Therapeutics Inc (UNCY) share price is $—, making it Sell.
Technical Analysis for UNCY
AI Technical UNCYAs of 2026-11-03, the technical board for Unicycive Therapeutics Inc (UNCY) reads strong sell: 0 indicators are flashing buy, 9 are indicating sell, and 4 are neutral. Price at $3.48 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 37.874, MACD stands at -0.216 (Sell), Stochastic %K stands at 32.561, Stochastic %D stands at 32.553 and CCI stands at -91.587.
UNCY trades below the 60-day SMA (4.57) and below the 200-day SMA (6.05). Immediate resistance sits at Classic R1 4.01, then R2 4.36. Support sits at Classic S1 3.33, then S2 2.99.
Unicycive Therapeutics Inc (UNCY) Support & Resistance Level
Unicycive Therapeutics Inc (UNCY) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 37.874 |
| STOCHk_14_3_3 | 32.561 |
| STOCHd_14_3_3 | 32.553 |
| CCI_20 | -91.587 |
| AO_5_34 | -0.451 |
| MOM_10 | -0.460 |
| MACD_12_26_9 | -0.216 |
Unicycive Therapeutics Inc (UNCY) Relative Strength Index (RSI_14) is 37.874, creating a Neutral signal.
Unicycive Therapeutics Inc (UNCY) Stochastic %K is 32.561, creating a Neutral signal.
Unicycive Therapeutics Inc (UNCY) Stochastic %D is 32.553, creating a Neutral signal.
Unicycive Therapeutics Inc (UNCY) CCI_20 is -91.587, creating a Neutral signal.
Unicycive Therapeutics Inc (UNCY) Awesome Oscillator (AO) is -0.451, creating a Sell signal.
Unicycive Therapeutics Inc (UNCY) Momentum (MOM) is -0.460, creating a Sell signal.
Unicycive Therapeutics Inc (UNCY) Moving Average Convergence Divergence (MACD) is -0.216, creating a Sell signal.
Unicycive Therapeutics Inc (UNCY) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 3.610 | Sell |
| MA_10 | 3.670 | Sell |
| MA_20 | 3.718 | Sell |
| MA_60 | 4.573 | Sell |
| MA_200 | 6.046 | Sell |
| MA_250 | 6.011 | Sell |
Unicycive Therapeutics Inc (UNCY) 5-Day simple moving average is 3.610, while Unicycive Therapeutics Inc (UNCY) share price is $, making it a Sell.
Unicycive Therapeutics Inc (UNCY) 10-Day simple moving average is 3.670, while Unicycive Therapeutics Inc (UNCY) share price is $, making it a Sell.
Unicycive Therapeutics Inc (UNCY) 20-Day simple moving average is 3.718, while Unicycive Therapeutics Inc (UNCY) share price is $, making it a Sell.
Unicycive Therapeutics Inc (UNCY) 60-Day simple moving average is 4.573, while Unicycive Therapeutics Inc (UNCY) share price is $, making it a Sell.
Unicycive Therapeutics Inc (UNCY) 200-Day simple moving average is 6.046, while Unicycive Therapeutics Inc (UNCY) share price is $, making it a Sell.
Unicycive Therapeutics Inc (UNCY) 250-Day simple moving average is 6.011, while Unicycive Therapeutics Inc (UNCY) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.